Birmingham spinout secures £800k for point of care
Birmingham-based Linear Diagnostics Ltd has secured £800,000 from the Midlands Engine Investment Fund (MEIF) and other investors in the company’s second round of funding, which will enable the company to commence the development of the hardware platform for its tests....
New biomaterials can be ‘fine-tuned’ for medical applications
Researchers in the UK and the United States have succeeded in ‘fine tuning’ a new thermoplastic biomaterial to enable both the rate at which it degrades in the body and its mechanical properties to be controlled independently. The material, a type of polyester, has...
New COVID-19 RNA test gives accurate results within minutes
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, and delivers accurate results. The method is described in a preprint paper (yet to be peer-reviewed) published on MedRxiv, where the...
Birmingham spinout Revitope Oncology Inc announces $10m investment
University of Birmingham spinout Revitope Oncology Inc has announced a $10m investment from leading Chinese biopharmaceutical company Junshi Biosciences. The $10m direct equity investment, in exchange for 9.9% of total Revitope Oncology shares, is in addition to...
Spinout 4D Biomaterials ramps up commercialisation for 3D tissue scaffolds
4D Biomaterials has been awarded funding by Innovate UK for the development and commercialisation of a new class of liquid resins that can be custom-printed into bioresorbable 3D tissue scaffolds providing accelerated and improved wound healing following major...
